These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38114732)

  • 41. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis.
    Siskind D; Orr S; Sinha S; Yu O; Brijball B; Warren N; MacCabe JH; Smart SE; Kisely S
    Br J Psychiatry; 2022 Mar; 220(3):115-120. PubMed ID: 35049446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia.
    Wykes T; Reeder C; Williams C; Corner J; Rice C; Everitt B
    Schizophr Res; 2003 Jun; 61(2-3):163-74. PubMed ID: 12729868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autistic traits and cognitive profiles of treatment-resistant schizophrenia.
    Nakata Y; Kanahara N; Kimura A; Niitsu T; Komatsu H; Oda Y; Ishikawa M; Hasegawa T; Kamata Y; Yamauchi A; Inazumi K; Kimura H; Iyo M
    Schizophr Res Cogn; 2020 Dec; 22():100186. PubMed ID: 32760657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive remediation in schizophrenia: What happens after 10 years?
    Buonocore M; Spangaro M; Bechi M; Trezzani S; Terragni R; Martini F; Agostoni G; Cocchi F; Cuoco F; Guglielmino C; Bosia M; Cavallaro R
    Schizophr Res Cogn; 2022 Sep; 29():100251. PubMed ID: 35402166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia.
    Costa-Dookhan KA; Rajji TK; Tran VN; Bowden S; Mueller DJ; Remington GJ; Agarwal SM; Hahn MK
    Sci Rep; 2021 Jan; 11(1):2004. PubMed ID: 33479273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients.
    Iasevoli F; D'Ambrosio L; Notar Francesco D; Razzino E; Buonaguro EF; Giordano S; Patterson TL; de Bartolomeis A
    Schizophr Res; 2018 Dec; 202():217-225. PubMed ID: 29934250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remediation of impairments in facial affect recognition in schizophrenia: efficacy and specificity of a new training program.
    Wölwer W; Frommann N; Halfmann S; Piaszek A; Streit M; Gaebel W
    Schizophr Res; 2005 Dec; 80(2-3):295-303. PubMed ID: 16125367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COMT and 5-HT1A-receptor genotypes potentially affect executive functions improvement after cognitive remediation in schizophrenia.
    Bosia M; Bechi M; Pirovano A; Buonocore M; Lorenzi C; Cocchi F; Bramanti P; Smeraldi E; Cavallaro R
    Health Psychol Behav Med; 2014 Jan; 2(1):509-516. PubMed ID: 25750798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Computer-assisted cognitive remediation therapy increases hippocampal volume in patients with schizophrenia: a randomized controlled trial.
    Morimoto T; Matsuda Y; Matsuoka K; Yasuno F; Ikebuchi E; Kameda H; Taoka T; Miyasaka T; Kichikawa K; Kishimoto T
    BMC Psychiatry; 2018 Mar; 18(1):83. PubMed ID: 29587688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered functional connectivity in anterior cingulate cortex subregions in treatment-resistant schizophrenia patients.
    Liu Y; Huang H; Qin X; Zheng F; Wang H
    Neurosci Lett; 2023 Sep; 814():137445. PubMed ID: 37597741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis.
    Mizuno Y; McCutcheon RA; Brugger SP; Howes OD
    Neuropsychopharmacology; 2020 Mar; 45(4):622-631. PubMed ID: 31766049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs.
    Iasevoli F; Avagliano C; Altavilla B; Barone A; D'Ambrosio L; Matrone M; Notar Francesco D; Razzino E; de Bartolomeis A
    Front Psychiatry; 2018; 9():553. PubMed ID: 30429802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive remediation therapy for outpatients with chronic schizophrenia: a controlled and randomized study.
    Penadés R; Catalán R; Salamero M; Boget T; Puig O; Guarch J; Gastó C
    Schizophr Res; 2006 Oct; 87(1-3):323-31. PubMed ID: 16750611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychological interventions for psychosis in adolescents.
    Datta SS; Daruvala R; Kumar A
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009533. PubMed ID: 32633858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Music rhythm perception and production relate to treatment response in schizophrenia.
    Honda S; Matsushita K; Noda Y; Tarumi R; Nomiyama N; Tsugawa S; Nakajima S; Mimura M; Fujii S
    Schizophr Res; 2023 Feb; 252():69-76. PubMed ID: 36634450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of Integrated Social Cognitive Remediation vs. Neurocognitive Remediation in Improving Functional Outcome in Schizophrenia: Concept and Design of a Multicenter, Single-Blind RCT (The ISST Study).
    Wölwer W; Frommann N; Lowe A; Kamp D; Weide K; Bechdolf A; Brockhaus-Dumke A; Hurlemann R; Muthesius A; Klingberg S; Hellmich M; Schmied S; Meyer-Lindenberg A;
    Front Psychiatry; 2022; 13():909370. PubMed ID: 35800017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of cognitive and functional improvement and normalization after cognitive remediation in patients with schizophrenia.
    Vita A; Deste G; De Peri L; Barlati S; Poli R; Cesana BM; Sacchetti E
    Schizophr Res; 2013 Oct; 150(1):51-7. PubMed ID: 23998953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach.
    Barone A; De Prisco M; Altavilla B; Avagliano C; Balletta R; Buonaguro EF; Ciccarelli M; D'Ambrosio L; Giordano S; Latte G; Matrone M; Milandri F; Francesco DN; Vellucci L; de Bartolomeis A
    J Psychiatr Res; 2022 Nov; 155():572-578. PubMed ID: 36206601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.